Author

Prasanth Viswanathan

University of Arkansas for Medical SciencesPrimary ORCID profile (0000-0001-7840-592X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Prasanth ViswanathaniD1 paper · Government Medical College

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Allison C. Farrar· 1 shared Alyssandra Navarro· 1 shared Andrew Murphy· 1 shared Daniel Dunham· 1 shared Jackson Gill· 1 shared Justine R Bersonda· 1 shared Karl W. BoehmeiD· 1 shared Mark ManzanoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Allison C. Farrar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The Mitochondrial Ubiquitin Ligase MARCHF5 Cooperates with MCL1 to Inhibit Apoptosis in KSHV-Transformed Primary Effusion Lymphoma Cell Lines

Prasanth Viswanathan, Justine R Bersonda, Jackson Gill, Alyssandra Navarro, Allison C. Farrar, Thomas Caldarera, Andrew Murphy, Daniel Dunham, Karl W. Boehme, Mark Manzano

This study identifies a genetic interaction between MCL1 and MARCHF5 in PEL cells, showing that MARCHF5 promotes cell survival by degrading NOXA, an antagonist of MCL1.

PLoS Pathogens · Oct 1, 2026Peer-reviewedCancer Biology